Arcadia Investment Management’s GSK GSK Stock Holding History

Arcadia Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-620	Closed	-$28K	–	301
2021 Q1	$28K	Buy	+620	New	+$28.1K	0.01%	228
2018 Q4	–	Sell	-47	Closed	-$2K	–	298
2018 Q3	$2K	Hold	47	–	–	﹤0.01%	317
2018 Q2	$2K	Hold	47	–	–	﹤0.01%	324
2018 Q1	$2K	Hold	47	–	–	﹤0.01%	334
2017 Q4	$2K	Sell	47 -278	-86%	-$12.8K	﹤0.01%	348
2017 Q3	$16K	Hold	325	–	–	﹤0.01%	311
2017 Q2	$18K	Hold	325	–	–	0.01%	296
2017 Q1	$17K	Hold	325	–	–	0.01%	340
2016 Q4	$16K	Hold	325	–	–	0.01%	275
2016 Q3	$18K	Hold	325	–	–	0.01%	278
2016 Q2	$18K	Hold	325	–	–	0.01%	350
2016 Q1	$16K	Buy	325 +47	+17%	+$2.34K	0.01%	234
2015 Q4	$14K	Buy	+278	New	+$14.2K	﹤0.01%	244

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arcadia Investment Management's GSK Position: Q2 2021 in Review

Arcadia Investment Management sold out of GSK (GSK) in Q2 2021, closing a stake of 620 shares — an estimated $28K sold.

Arcadia Investment Management first reported a position in GSK in Q4 2015 and held it in 13 quarters. The position peaked at $28K in Q1 2021. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

Arcadia Investment Management reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
Arcadia Investment Management sold 620 GSK shares in Q2 2021, an estimated $28K.
Arcadia Investment Management first reported a position in GSK in Q4 2015 and held it in 13 quarters.
Arcadia Investment Management's GSK position peaked at $28K in Q1 2021.
798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Arcadia Investment Management's 13F filing for Q2 2021, filed 2 Aug 2021.